Stanford's Kundaje: AI won't solve rare disease — the bottlenecks are measurement and delivery
anshulkundaje · x · 2026-11-07
Responding to claims that AI could crack rare diseases, computational genomics researcher Anshul Kundaje says no. In his view the real bottlenecks are measuring the right entities in the right cell contexts (fetal developmental and disease contexts), understanding fundamental developmental biology, delivering therapeutics into the right cells, and more reliable screening — not a lack of ideas or compute.
Related event: Stanford professor argues rare disease bottleneck is biology, not AI(10 posts)→
More from AGI Musings
- Defenders Can Match 1,000 Attacking AI Agents—and Hold an Information Edge — marktenenholtz · 2026-11-08
- 'Old Man Yells at Moon' meme captures the coming AGI productivity paradox — yunta_tsai · 2026-11-08
- Agents Will Toxicify the Open Internet; Private High-Trust Networks Win — sull · 2026-11-08
- LLMs Are Now Both Authors and Reviewers, Quip Highlights Peer Review Loop — miniapeur · 2026-11-08
- 3,000 years of frozen family careers: why abundance, not money, expands life choices — yunta_tsai · 2026-11-08
- Box CEO Aaron Levie: AI Has Widened the Engineer Gap to at Least 100x — 2C_ornot2C · 2026-11-08